Effects of pharmacological drugs on synaptic activity of hippocampus

Cover Page


The search for physiologically active drugs with precognitive action and the study of mechanisms of their influence on the brain represent important tasks of neurobiology and neuropharmacology. The paper considers methodical and scientific approaches to the study of effects of different memoryenhancing drugs on synaptic activity of area CA1 of hippocampus. Special attention was paid to the modulation of longtermpotentiation, previously disturbed by hypoxia or alcohol perfusion, by peptide analogues of piracetam. It was demonstrated using patch clamp technique that one of these peptides, Noopept, increases inhibitory synaptic transmission, probably due to blockade of potassium channels in the terminals of inhibitory interneurons.


About the authors

V. G. Skrebitsky

Research Center of Neurology, Russian Academy of Medical Sciences, Moscow

Author for correspondence.
Email: platonova@neurology.ru
Russian Federation

N. A. Kapay

Research Center of Neurology, Russian Academy of Medical Sciences, Moscow

Email: platonova@neurology.ru
Russian Federation

V. I. Derevyagin

Research Center of Neurology, Russian Academy of Medical Sciences, Moscow

Email: platonova@neurology.ru
Russian Federation

R. V. Kondratenko

Research Center of Neurology, Russian Academy of Medical Sciences, Moscow

Email: platonova@neurology.ru
Russian Federation


  1. Виноградова О.С. Гиппокамп и память. М.: Наука, 1975.
  2. Гудашева Т.А., Островская Р.У., Максимова Ф.В. и др. О
  3. возможной структурноофункциональной связи пирацетама и
  4. вазопрессина. Хим. фарм. журн. 1988; 3: 271–275.
  5. Гудашева Т.А., Островская Р.У., Трофимов С.С. и др. Пептидные
  6. аналоги пирацетама как лиганды предполагаемых ноотропных
  7. рецепторов. Хим. фарм. журн. 1985; 11: 1322–1328.
  8. Капай Н.А, Чепкова А.Н., Гудашева Т.А. и др. Амид
  9. пироглютамиласпарагина нормализует развитие длительной
  10. потенциации в срезах гиппокампа крыс. Бюл. эксп. биол. и мед.
  11. ; 8: 176–179.
  12. Скребицкий В.Г. Влияние нейрорегуляторов на синаптическую
  13. активность гиппокампа. Успехи физиол. наук 1985; 4: 35–48.
  14. Чепкова А.Н., Капай Н.А., Дореули Н.В. и др. Влияние амида
  15. пироглутамиласпарагина на пластические свойства
  16. синаптической передачи в гиппокампе. Бюл. эксп. биол. мед.
  17. ; 7: 68–71.
  18. Bliss T.V. P., Lomo T. Longglasting potentiation of synaptic trans￿
  19. mission in the dentate area of the anaesthetized rabbit following stimu￿
  20. lation of the perforant path. J. Physiol. 1973; 232: 331–336.
  21. Chepkova A.N., French P., De Wied D. et al. Longglasting enhance￿
  22. ment of synaptic excitability of CA1/subiculum neurons of the rat ven￿
  23. tral hippocampus by vasopressin and vasopressin(448). Brain Res. 1995;
  24. : 255–266.
  25. Chepkova A.N., Doreulee N.V., Trofimov S.S. et al. Nootropic comm
  26. pound LLpyroglutamyllDDalanineeamide restores hippocampal longg
  27. term potentiation impaired by exposure to ethanol in rats. Neurosci.
  28. Lett. 1995; 188: 163–166.
  29. Chepkova A.N., Kapai N.A., Skrebitskii V.G. Arginine vasopressin
  30. fragment AVP(449)facilitates induction of longgterm potentiation in the
  31. hippocampus. Bull. Exp. Biol. Med. 2001; 131: 136–138.
  32. Gavrilova S.A., Us K.S., Ostrovskaia R.U. et al. Neuroprotective
  33. activity of the prolineecontaining dipeptide noopept on the model of
  34. brain ischemia induced by the middle cerebral artery occlusion. Exp.
  35. Clin. Pharmacol. 2006; 69: 16–18.
  36. Giurgea C. Vers une pharmacologie de l’active integrative du cerveau.
  37. Tentative du concept nootrope en psychopharmacologies. Actualites
  38. Pharmacologiques 1972; 25: 115–156.
  39. Gudasheva T.A., Boyko S.S., Ostrovskaya R.U. et al. The major
  40. metabolite of dipeptide piracetam analogue GVSS111 in rat brain and its
  41. similarity to endogenous neuropeptide cyclooLLprolylglycine. Eur. J.
  42. Drug Metab. Pharmacokinet. 1997; 22: 245–252.
  43. Kinney G.G., Patino P., MermettBouvier Y. et al. Cognitionnenhancc
  44. ing drugs increase stimulated hippocampal theta rhythm amplitude in
  45. the urethaneeanesthetized rat. J. Pharmacol. Exp. Ther. 1999; 291:
  46. –106.
  47. Kozhemiakin M.B., Draguhn A., Skrebitsky V.G. Layerrspecific
  48. potentiation of evoked IPSCs in rat hippocampal CA1 pyramidal cells
  49. by lanthanum. Brain Res. Bull. 2004; 64: 97–101.
  50. McNaughton N., Kocsis B., Hajуs M. Elicited hippocampal theta
  51. rhythm: a screen for anxiolytic and procognitive drugs through changes
  52. in hippocampal function? Behav. Pharmacol. 2007; 18: 329–346.
  53. Ostrovskaya R.U., Gruden M.A., Bobkova N.A. et al. The nootropic
  54. and neuroprotective prolineecontaining dipeptide noopept restores spaa
  55. tial memory and increases immunoreactivity to amyloid in an
  56. Alzheimer’s disease model. J. Psychopharmacol. 2007; 21: 611–619.
  57. Rong X.W., Chen X.F., Du Y.C. Potentiation of synaptic transmission
  58. by neuropeptide AVP448 (ZNC(C)PR) in rat hippocampal slices.
  59. Neuroreport 1993; 4: 1135–1138.
  60. Sara S.J., DaviddRemacle M., Weyers M. et al. Piracetam facilitates
  61. retrieval but does not impair extinction of barrpressing in rats.
  62. Psychopharmacology (Berl.) 1979; 61: 71–75.



Abstract: 1102

PDF (Russian): 775

Article Metrics

Metrics Loading ...



Copyright (c) 2008 Skrebitsky V.G., Kapay N.A., Derevyagin V.I., Kondratenko R.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies